Scientists at San Diego-based Novocell were able to convert human embryonic stem cells into cells that secrete insulin and control diabetes in mice whose insulin-producing islet cells have been destroyed. The company plans to create a continuous pool of human embryonic stem cells ready for use in human therapies to treat people with diabetes.

Related Summaries